In 2022 Susan Wojcicki was on top of the world—CEO of YouTube, parent to five kids and running a few miles a day—when she received a shocking diagnosis: metastatic lung cancer. She soon resigned from ...

New York, NY, November 6, 2025 — The International Rescue Committee (IRC) is proud to announce that Pulitzer Prize-winning photojournalist Lynsey Addario will receive the IRC’s 2025 Freedom Award, and ...

Climb Bio appointed Susan Altschuller chief financial officer as the clinical-stage biotechnology company pushes ahead with the development of two flagship therapeutics for patients with ...

WELLESLEY HILLS, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...

Now that President Donald Trump is president once more and flexing the might of the federal government to punish the press and pressure media companies, Democratic critics are crying foul and suddenly ...

23andMe, a distressed genetic testing company that filed for bankruptcy this year, has received another potential lifeline. A bankruptcy judge approved the sale of the company’s assets and business ...

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. Related Articles NYC woman sues Chipotle, DoorDash ...

NEW YORK (AP) — Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. That means Wojcicki's nonprofit TTAM Research ...

(From left to right) Anne Wojcicki, Janet Wojcicki and Susan Wojcicki attend the 7th Annual Breakthrough Prize Ceremony at NASA Ames Research Center on Nov. 4, 2018 in Mountain View, Calif. Getty ...

23andMe co-founder Anne Wojcicki is slated to regain control of her DNA-testing company after a nonprofit she controls outbid rivals in a bankruptcy auction. TTAM Research Institute, a nonprofit ...

Anne Wojcicki, cofounder and former CEO of 23andMe, will regain control of the company after her nonprofit, TTAM Research Institute, agreed to purchase nearly all of its assets for $305 million. In ...